ADIM
VTR icon

Alpha DNA Investment Management’s Ventas VTR Stock Holding History

Alpha DNA Investment Management’s Portfolio VTR Stock Details VTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-35
Closed -$1K – 647
2021
Q1 		$1K Sell
35
-729
-95% -$37.4K ﹤0.01% 659
2020
Q4 		$37K Buy
+764
New +$35.3K 0.04% 203

Other funds holding VTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Alpha DNA Investment Management's VTR Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Ventas (VTR) in Q2 2021, closing a stake of 35 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in VTR in Q4 2020 and held it in 2 quarters. The position peaked at $37K in Q4 2020. 647 funds tracked by Wall St. Rank hold VTR as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Ventas position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 35 Ventas shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Ventas in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Ventas position peaked at $37K in Q4 2020.
  • 647 funds tracked by Wall St. Rank held Ventas as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.